Tandem Diabetes Care, Inc. (TNDM)
28.74
+0.48
(+1.70%)
USD |
NASDAQ |
Feb 24, 13:45
Tandem Diabetes Care Research and Development Expense (Quarterly) : 46.07M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 352.90M |
| Insulet Corp. | 90.90M |
| iRhythm Holdings, Inc. | 21.05M |
| Stryker Corp. | 380.00M |
| Abbott Laboratories | 721.00M |